Skip to content

ClearUP Longitudinal Pilot Study

ClearUP Longitudinal Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03888274
Enrollment
30
Registered
2019-03-25
Start date
2018-11-29
Completion date
2019-03-01
Last updated
2020-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congestion, Sinus Pain

Brief summary

Single arm, open label pilot study assessing the longitudinal home use of ClearUp Sinus Pain Relief for four weeks.

Interventions

DEVICEClearUP Sinus Pain Relief

Microcurrent Device Treatment

Sponsors

Tivic Health Systems
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 71 Years
Healthy volunteers
No

Inclusion criteria

* 18-71 years of age (inclusive) * Present with symptoms of sinus pain or facial pain in the forehead, periorbital, facial, or nasal region * Current pain score ≥ 5 (Numeric Rating Scale 0-10) * Frequency of sinus/facial pain at least twice weekly for 1 month * Able to read and understand English * Agree to participate in the study * Able and willing to provide Informed Consent

Exclusion criteria

* Do not meet Inclusion Criteria * Currently taking or recently taken any oral steroid medications in the last 90 days * Sinus surgery in previous 90 days * History of Chronic Migraine (≥ 15 headache days per month) * Pain location in the vertex, occiput, or temporal region of the skull or in mandibular region * Purulent rhinorrhea

Design outcomes

Primary

MeasureTime frameDescription
Numeric Rating Scale for Pain4 weeksChange in Numeric Rating Scale for Pain from Baseline to Four Weeks. Scale range 0, no pain, to 10 severe pain.

Secondary

MeasureTime frameDescription
Congestion Quantifier 74 WeeksChange in Congestion Quantifier 7 from Baseline to Four Weeks. Congestion Quantifier 7 is a 7 item questionnaire that quantifies congestion symptom severity. It is scored from 0 (no congestion symptoms) to 28 (severe congestions symptoms).
Numeric Rating Scale for Pain6 hoursAcute Change in Numeric Rating Scale for Pain from Baseline to 6 Hours. Scale range 0, no pain, to 10 severe pain.

Countries

United States

Participant flow

Participants by arm

ArmCount
Active
ClearUP Sinus Pain Relief: Microcurrent Device Treatment
30
Total30

Baseline characteristics

CharacteristicActive
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
1 Participants
Age, Categorical
Between 18 and 65 years
29 Participants
Age, Continuous43.4 Years
STANDARD_DEVIATION 12.1
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
30 participants
Sex: Female, Male
Female
21 Participants
Sex: Female, Male
Male
9 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 30
other
Total, other adverse events
4 / 30
serious
Total, serious adverse events
0 / 30

Outcome results

Primary

Numeric Rating Scale for Pain

Change in Numeric Rating Scale for Pain from Baseline to Four Weeks. Scale range 0, no pain, to 10 severe pain.

Time frame: 4 weeks

ArmMeasureGroupValue (MEAN)Dispersion
ActiveNumeric Rating Scale for PainBaseline6.5 score on a scaleStandard Error 0.2
ActiveNumeric Rating Scale for Pain4 Weeks3.6 score on a scaleStandard Error 0.36
Secondary

Congestion Quantifier 7

Change in Congestion Quantifier 7 from Baseline to Four Weeks. Congestion Quantifier 7 is a 7 item questionnaire that quantifies congestion symptom severity. It is scored from 0 (no congestion symptoms) to 28 (severe congestions symptoms).

Time frame: 4 Weeks

ArmMeasureGroupValue (MEAN)Dispersion
ActiveCongestion Quantifier 7Baseline18.1 score on a scaleStandard Error 0.85
ActiveCongestion Quantifier 74 Weeks11.0 score on a scaleStandard Error 1.05
Secondary

Numeric Rating Scale for Pain

Acute Change in Numeric Rating Scale for Pain from Baseline to 6 Hours. Scale range 0, no pain, to 10 severe pain.

Time frame: 6 hours

ArmMeasureGroupValue (MEAN)Dispersion
ActiveNumeric Rating Scale for PainBaseline6.5 score on a scaleStandard Error 0.2
ActiveNumeric Rating Scale for Pain6 Hours4.3 score on a scaleStandard Error 0.37

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026